Wylie Vale

6.9k total citations · 2 hit papers
65 papers, 5.6k citations indexed

About

Wylie Vale is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Wylie Vale has authored 65 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Molecular Biology and 15 papers in Reproductive Medicine. Recurrent topics in Wylie Vale's work include Growth Hormone and Insulin-like Growth Factors (21 papers), Stress Responses and Cortisol (13 papers) and Hypothalamic control of reproductive hormones (10 papers). Wylie Vale is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (21 papers), Stress Responses and Cortisol (13 papers) and Hypothalamic control of reproductive hormones (10 papers). Wylie Vale collaborates with scholars based in United States, Switzerland and Canada. Wylie Vale's co-authors include Catherine Rivier, Joan Vaughan, Hélène Meunier, Paul E. Sawchenko, Jean Rivier, Mark E. Smith, Gayle Yamamoto, Ronald M. Evans, Jean Rivier and Nils Billestrup and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Wylie Vale

65 papers receiving 5.4k citations

Hit Papers

Distribution of mRNAs encoding CRF receptors in brai... 1983 2026 1997 2011 2000 1983 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wylie Vale United States 34 2.0k 1.9k 1.8k 964 814 65 5.6k
Louise M. Bilezikjian United States 37 3.0k 1.5× 2.2k 1.2× 2.5k 1.3× 1.1k 1.2× 697 0.9× 62 7.3k
Jean Rivier United States 40 1.6k 0.8× 2.0k 1.1× 3.4k 1.8× 1.9k 2.0× 1.6k 2.0× 76 7.2k
John C. Porter United States 47 1.5k 0.8× 2.4k 1.3× 1.2k 0.7× 966 1.0× 2.3k 2.8× 177 7.5k
W. Vale United States 38 1.2k 0.6× 1.6k 0.9× 3.9k 2.1× 2.0k 2.0× 412 0.5× 64 6.5k
Richard I. Weiner United States 44 3.0k 1.5× 2.0k 1.1× 648 0.4× 956 1.0× 2.1k 2.6× 125 7.4k
Jimmy D. Neill United States 48 1.6k 0.8× 2.2k 1.2× 865 0.5× 1.3k 1.3× 3.4k 4.1× 110 7.5k
Carl Denef Belgium 41 1.6k 0.8× 2.4k 1.3× 737 0.4× 270 0.3× 988 1.2× 143 5.5k
Malcolm V. Lane United States 22 1.7k 0.9× 2.4k 1.2× 868 0.5× 632 0.7× 1.2k 1.4× 35 6.1k
Anthony S. Liotta United States 37 1.1k 0.6× 841 0.4× 859 0.5× 457 0.5× 736 0.9× 48 3.3k
Ivor M.D. Jackson United States 40 1.3k 0.7× 3.0k 1.6× 1.0k 0.6× 575 0.6× 1.5k 1.9× 196 6.6k

Countries citing papers authored by Wylie Vale

Since Specialization
Citations

This map shows the geographic impact of Wylie Vale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wylie Vale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wylie Vale more than expected).

Fields of papers citing papers by Wylie Vale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wylie Vale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wylie Vale. The network helps show where Wylie Vale may publish in the future.

Co-authorship network of co-authors of Wylie Vale

This figure shows the co-authorship network connecting the top 25 collaborators of Wylie Vale. A scholar is included among the top collaborators of Wylie Vale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wylie Vale. Wylie Vale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jamieson, Pauline, Mark E. Cleasby, Nicholas M. Morton, et al.. (2009). Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and insulin resistance on a high fat diet. 19. 1 indexed citations
2.
Harrison, Craig A., Ezra Wiater, Peter C. Gray, et al.. (2004). Modulation of activin and BMP signaling. Molecular and Cellular Endocrinology. 225(1-2). 19–24. 34 indexed citations
3.
Spina, Mariarosa, Emilio Merlo‐Pich, Yvette Akwa, et al.. (2002). Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology. 160(2). 113–121. 68 indexed citations
4.
Viau, Victor, Jackson C. Bittencourt, R.K.W. Chan, et al.. (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. The Journal of Comparative Neurology. 428(2). 191–212. 893 indexed citations breakdown →
5.
Fischer, Wolfgang, et al.. (1999). The Disulfide Bond Arrangement in the Extracellular Domain of the Activin Type II Receptor. Journal of Protein Chemistry. 18(4). 437–446. 5 indexed citations
6.
Petraglia, Felice, Anna Maria Di Blasio, Pasquale Florio, et al.. (1997). High levels of fetal membrane activin βA and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor. Journal of Endocrinology. 154(1). 95–101. 41 indexed citations
7.
Turnbull, Andrew V., Wylie Vale, & Catherine Rivier. (1996). Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. European Journal of Pharmacology. 303(3). 213–216. 74 indexed citations
8.
Rivier, Catherine, Hélène Meunier, Veronica J. Roberts, & Wylie Vale. (1990). Inhibin: Role and Secretion in the Rat. Elsevier eBooks. 46. 231–259. 16 indexed citations
9.
Brown, Marvin R., Joan Vaughan, Jon C. Walsh, et al.. (1990). Endothelin releasing activity in calf serum and porcine follicular fluid. Biochemical and Biophysical Research Communications. 173(3). 807–815. 12 indexed citations
10.
11.
Roberts, Veronica J., Hélène Meunier, Joan Vaughan, et al.. (1989). PRODUCTION AND REGULATION OF INHIBIN SUBUNITS IN PITUITARY GONADOTROPES. Endocrinology. 124(1). 552–554. 211 indexed citations
12.
Meunier, Hélène, Stefan Cajander, Veronica J. Roberts, et al.. (1988). Rapid Changes in the Expression of Inhibin α-, βA-, and βB-Subunits in Ovarian Cell Types During the Rat Estrous Cycle. Molecular Endocrinology. 2(12). 1352–1363. 179 indexed citations
13.
Yu, John, Li‐En Shao, V. Lemas, et al.. (1987). Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature. 330(6150). 765–767. 248 indexed citations
14.
Vale, Wylie, Jean Rivier, Joan Vaughan, et al.. (1987). Purification and Characterization of an FSH Releasing Protein from Porcine Ovarian Follicular Fluid. Obstetrical & Gynecological Survey. 42(2). 108–108. 59 indexed citations
15.
Vance, Mary Lee, William S. Evans, Donald L. Kaiser, et al.. (1986). The effect of intravenous, subcutaneous, and intranasal GH-RH analog, [Nle27]GHRH(1-29)-NH2, on growth hormone secretion in normal men: Dose-response relationships. Clinical Pharmacology & Therapeutics. 40(6). 627–633. 20 indexed citations
16.
Rivier, Catherine, Wylie Vale, & Jean Rivier. (1983). Effects of gonadotropin releasing hormone agonists and antagonists on reproductive functions. Journal of Medicinal Chemistry. 26(11). 1545–1550. 19 indexed citations
18.
Crowley, W F, et al.. (1981). THERAPEUTIC USE OF PITUITARY OESENSITIZATION WITH A LONG-ACTING LHRM AGONIST: A POTENTIAL NEW TREATMENT FOR IDIOPATHIC PRECOCIOUS PUBERTY*. The Journal of Clinical Endocrinology & Metabolism. 52(2). 370–372. 196 indexed citations
19.
Peters, Jürgen, et al.. (1980). Somatostatin administration in the carcinoid syndrome. 2. 1211. 1 indexed citations
20.
Burgus, Roger, Thomas F. Dunn, Dominic M. Desiderio, et al.. (1970). Biological Activity of Synthetic Polypeptide Derivatives Related to the Structure of Hypothalamic TRF. Endocrinology. 86(3). 573–582. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026